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The Ras family GTPase, R-Ras, elicits important integrin-dependent cellular behaviors such as adhesion, spreading and
migration. While oncogenic Ras GTPases and R-Ras share extensive sequence homology, R-Ras induces a distinct set of
cellular behaviors. To explore the structural basis for these differences, we asked whether the unique N-terminal 26 amino
acid extension of R-Ras was responsible for R-Ras–specific signaling events. Using a 32D mouse myeloid cell line, we
show that full-length R-Ras activates Rac and induces Rac-dependent cell spreading. In contrast, truncated R-Ras lacking
its first 26 amino acids fails to activate Rac, resulting in reduced cell spreading. Truncated R-Ras also stimulates more 3
integrin-dependent cell migration than full-length R-Ras, suggesting that the N-terminus may negatively regulate cell
movement. However, neither the subcellular localization of R-Ras nor its effects on cell adhesion are affected by the
presence or absence of the N-terminus. These results indicate that the N-terminus of R-Ras positively regulates specific
R-Ras functions such as Rac activation and cell spreading but negatively regulates R-Ras–mediated cell migration.
INTRODUCTION
The Ras family of small GTPases is essential for many highly
complex cellular processes such as proliferation, differenti-
ation, survival, and migration (Katz and McCormick, 1997).
Unifying structural similarities among Ras family members
include a highly conserved guanine nucleotide binding se-
quence and two “switch” regions that change conformation
upon GDP release and subsequent GTP binding, a core
effector loop that contacts target proteins involved in down-
stream signaling and one or more acylation sites at the
C-terminus that facilitate membrane localization. Cycling
between the inactive GDP-bound and the active GTP-bound
conformations allows for precise regulation of G protein
signaling.
R-Ras defines a Ras subfamily that also includes TC21/R-
Ras2 and M-Ras/R-Ras3 (Reuther and Der, 2000). These
three GTPases have highly divergent C-terminal sequences
that distinguish them from other members of the Ras family,
yet all three are highly homologous (50% identity) to the
proto-oncogene, H-Ras, at key amino acid residues. For
example, point mutations at amino acid positions 12 or 61
that activate H-Ras by lowering its intrinsic GTPase activity,
also activate R-Ras at its corresponding residues (Saez et al.,
1994). In addition, H-Ras and R-Ras share an identical 9
amino acid core effector domain. Consequently, H-Ras and
R-Ras bind many of the same signaling proteins in vitro,
such as phosphatidylinositol 3-kinase  (p110 PI3K; Marte
et al., 1997), p101 PI3K (Suire et al., 2002), c-Raf (Rey et al.,
1994; Spaargaren et al., 1994), Nore1 (Vavvas et al., 1998;
Oertli et al., 2000), the guanine nucleotide exchange factor
(GEF) Ras-GRF (Gotoh et al., 1997), and the GTPase activat-
ing protein, Ras-GAP (Rey et al., 1994). Furthermore, R-Ras
shares some common functions with oncogenic GTPases,
including stimulation of cell proliferation (Yu and Feig,
2002) and transformation (Cox et al., 1994; Saez et al., 1994).
Despite sharing common binding partners in vitro, however,
R-Ras does not mimic all known effects of oncogenic Ras
(Rey et al., 1994; Huff et al., 1997). For example, R-Ras does
not inhibit integrin affinity modulation (Sethi et al., 1999),
activate the mitogen-activated protein kinase (MAPK;
Osada et al., 1999; Self et al., 2001), or become activated by
mSOS, a ubiquitous GEF for Ras (Gotoh et al., 1997).
The first clue to the unique cellular functions of R-Ras
came from the finding that expression of an activated mu-
tant of R-Ras made cells highly adherent in an integrin-
dependent manner (Zhang et al., 1996). These authors also
showed that R-Ras increased the affinity of the prototype
platelet integrin, IIb3, for soluble ligand, suggesting that
R-Ras regulates integrins through an “inside-out” signaling
mechanism. R-Ras has also been implicated in cell spreading
(Berrier et al., 2000), cell survival (Suzuki et al., 1997; Osada
et al., 1999) and haptotactic migration (Keely et al., 1999;
Suzuki et al., 2000).
Previous structural studies of R-Ras have focused on its
core effector domain (Osada et al., 1999; Oertli et al., 2000)
and C-terminal sequences (Wang et al., 2000; Hansen et al.,
2002). Mutation of the effector domain diminishes R-Ras
functions, but does not reveal how R-Ras achieves specificity
in vivo (Osada et al., 1999; Oertli et al., 2000). In a recent
study of H-Ras/R-Ras chimeras, the C-terminal 26 amino
acid residues of R-Ras in the context of an H-Ras chimera
blocked H-Ras effects on integrins (Hansen et al., 2002).
These data are consistent with the idea that diverse C-
terminal sequences within the hyper-variable region of Ras
GTPases contribute to signaling specificity.
An unexplored region of great sequence diversity among
Ras family GTPases is the N-terminus. R-Ras contains a
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unique 26 amino acid sequence at its N-terminus, whereas
TC21 and M-Ras contain unique 12 and 13 amino acid
sequences respectively. In addition to its novel sequence, the
N-terminus of R-Ras is highly glycine- and proline-rich and
contains a noncanonical class I SH3 binding motif. To ad-
dress the importance of the N-terminus of R-Ras with re-
spect to integrin-dependent cellular functions, we deleted
the first 26 amino acids of activated R-Ras and asked how
this deletion affected the ability of R-Ras to stimulate inte-
grin-dependent events such as cell adhesion, spreading and
migration.
MATERIALS AND METHODS
Cells, Media, and Reagents
Mouse 32D myeloid progenitor cells and WEHI helper cells were a generous
gift of Dr. A. S. Baldwin, University of North Carolina (Reuther et al., 1998).
Cells were cultured in suspension in 10-cm dishes in 32D media (RPMI 1640
containing 10% heat-inactivated fetal bovine serum [FBS] and 10% WEHI
conditioned media). K562 cells, a generous gift of Dr. S. D. Blystone, were
cultured in Iscove’s media with 9% heat-inactivated FBS.
Purified, human vitronectin (Vn) from Chemicon (Temecula, CA) was used
for cell adhesion and microscopy experiments. Purified human fibrinogen
(Fg) was from Enzyme Research Laboratories (South Bend, IN). Dimer-spe-
cific anti-integrin IIb3 antibody 1B5 was a generous gift from Dr. Susan
Smyth, UNC-Chapel Hill (Smyth et al., 2000). Anti-integrin blocking antibod-
ies to v (clone RMV-7), 1 (clone Ha2/5), 3 (clone 2C9.G2), or control
antibodies (clone G235–1 for 1; clone A19–3 for 3) were from BD Bio-
sciences PharMingen (San Diego, CA). Anti-PP2A antibody was from BD
Transduction Laboratories (Lexington, KY). The monoclonal anti-Rac antibody
used was clone 23A8 (Upstate Biotechnology, Lake Placid, NY). The phospho-
specific and total Akt antibodies were from Cell Signaling Technologies (Beverly,
MA). All pharmacological protein inhibitors were from Calbiochem (La Jolla,
CA).
Vectors
Myc-tagged R-Ras constructs were generated from existing plasmids kindly
provided by Dr. Adrienne Cox (empty pCGN, pCGN Q87L, G38V, and G41A
R-Ras vectors; University of North Carolina) and Dr. Alan Hall (S43N and WT
alleles; University College, London). PCR products were generated using
r-ras–specific oligonucleotides with BamHI (5) and EcoRI (3) sites, digested,
and ligated into the mammalian expression vector pCMV-3b (Stratagene,
La Jolla, CA). GFP-tagged R-Ras constructs were made by PCR using the
pCMV R-Ras plasmids described above as templates to generate EcoRI-BamHI
fragments, which were cloned into the pEGFP-C2 vector (Clontech, Palo Alto,
CA). GFP-R-Ras proteins were functional because they stimulated cell adhe-
sion to immobilized ligands. GFP-dynamin was a gift from Dr. JoAnn Trejo
(University of North Carolina). Myc-tagged dominant-negative Rac and
Cdc42 (both S17N) as well as activated Rac and Cdc42 (both Q61L) plasmids
were a generous gift from Dr. Keith Burridge (University of North Carolina).
The pGL-3 luciferase plasmid was obtained from Promega (Madison, WI).
This plasmid continually transcribes the luc gene, resulting in constitutive
luciferase production.
Deletion PCR was used to remove the first 26 codons of R-Ras. The template
was pCMVR-Ras Q87L, which contains an activating point mutation at codon
87. The forward oligonucleotide sequence begins with an XbaI restriction
endonuclease site 5 of sequences in the r-ras open reading frame starting at
codon 26: GCCGTCTAGAAGCGAGACACACAAGCTGGTG. The reverse
oligonucleotide also begins with an XbaI site but anneals to the noncoding
strand of the myc sequence in pCMV: GCCGTCTAGACAGATCCTCTTCA-
GAGATGAG. A linear 5-kb fragment was generated by PCR using Pfu
polymerase (Stratagene) that was digested with XbaI. The digested fragment
was ligated to itself to generate pCMV N87L R-Ras. To confirm the absence
of PCR-induced mutations, all pCMV constructs were sequenced with T3 and
T7 oligonucleotides. All plasmids to be transfected into cells were purified
using a low endotoxin protocol (Qiagen, Chatsworth, CA).
Electroporation
We found that transient transfection was necessary to preserve R-Ras pheno-
types, because stable transfection methods resulted in decreased R-Ras ex-
pression over time (unpublished data). Cells (1–2  107) were added to a
sterile 0.4-cm cuvette, incubated with plasmids, and electroporated using a
Gene Pulser II apparatus at 260 V and 960 F capacitance. Cells were imme-
diately returned to 10 ml of warm media containing 20% serum and allowed
to recover at 37°C for at least 16 h. All equipment was from BioRad (Rich-
mond, CA).
Immunoblotting
Mouse 32D cells were electroporated with 5 g plasmid DNA as above,
harvested with 3 ml of nonenzymatic cell dissociation solution (CDS, Spe-
cialty Media, Phillipsburg, NJ), washed once, and diluted to 3–4  106
cells/ml. Approximately 2  106 cells were then lysed in fresh RIPA buffer (50
mM Tris, pH 7.5, 150 mM NaCl, 1% NP-40, 0.5% deoxycholate, 0.1% SDS, 2
mM NaF, and protease inhibitor cocktail) for 15 min on ice. The lysate was
clarified by centrifugation and an equal number of cell equivalents was
loaded for SDS-PAGE. Proteins were transferred to PVDF membranes by a
semidry transfer method (Trans-Blot from BioRad). Blots were incubated with
primary antibody for 1 h at a concentration of 1 g/ml for anti-myc antibody
(clone 9E10; Covance, Madison, WI), 0.4 g/ml for anti-R-Ras (C-19; Santa
Cruz Biotechnology, Santa Cruz, CA) and 0.25 g/ml for anti-PP2A (protein
phosphatase 2A; Transduction Laboratories). PP2A was used as a loading
control since levels were not affected by expression of R-Ras. Bands were
visualized with ECL (Amersham, Piscataway, NJ) or Western Lightning (Per-
kin Elmer-Cetus, Norwalk, CT). Horseradish peroxidase secondary antibod-
ies were from Amersham.
NIH 3T3 cells were transfected with 10 g DNA using Lipofectamine 2000
as per manufacturer’s instructions. Lysates were obtained and processed as
described above.
Indirect Immunofluorescence and Confocal Microscopy
For 32D cell microscopy, cells were electroporated with 5 g of pCMV- or
pCGN-based plasmids as indicated in the figure legends, washed once, and
8–10  106 cells were loaded onto coverslips coated with the indicated
concentrations of extracellular matrix protein. Adhesion proceeded for 30–60
min at 37°C. Cells were fixed for 30 min at room temperature (RT) with 4%
paraformaldehyde followed by permeabilization in 0.2% Triton X-100 in
phosphate-buffered saline (PBS). The 9E10 anti-myc (1 g/ml), anti-HA an-
tibody (1 g/ml; clone 12CA5; Boehringer Mannheim, Indianapolis, IN) or
polyclonal anti-c-myc (0.5 g/ml; Santa Cruz) primary antibodies were incu-
bated with cells in 3% bovine serum albumin (BSA) for 1 h at RT. After 3–4
washes with PBS, goat anti-mouse IgG-Alexa 488 at 1 g/ml was added
simultaneously with phalloidin-Alexa 568 at 0.1 U/ml (1:2000) for 30 min at
RT in the dark. Both secondary antibody and phalloidin were from Molecular
Probes (Eugene, OR). When c-myc was detected in the absence of phalloidin,
a goat anti-rabbit IgG-Alexa 568 secondary was used. Coverslips were in-
verted onto a drop of FluorSave antibleaching reagent (Calbiochem) and
viewed after storage overnight at 4°C on an Olympus IX70 inverted confocal
microscope (Lake Success, NY). Confocal images were captured using a 60
PlanApo lens and Fluoview software. K562 cells were processed as above
except that cells adhered to 1 g/ml fibronectin for 2 h and were electropo-
rated with 15 g of plasmid DNA. Epifluorescence cell morphology images
were taken with a Roper HQ cooled CCD camera (Roper Scientific, Tucson,
AZ) mounted on a Nikon TE300 inverted microscope (Melville, NY).
For scoring of filopodia-like structures, cells were fixed and stained as
above and 100 R-Ras–expressing cells per transfection condition for each
experiment from three independent experiments were scored. Scored cells
had round cell bodies and 2–4 protrusions (indicated in the figure legends)
that were approximately a cell length or longer.
For scoring Rac-like morphology, 5 g of pCMV Rac Q61L (CA-Rac) or 2 g
of either pCGN N87L R-Ras or pCGN Q87L R-Ras were transfected with 10
g pCMV Rac S17N (DN-Rac), as indicated in Figure 8. Total plasmid mass
for each transfection was 15 g.
Cell Adhesion Assay
The indicated concentrations of ECM protein were coated onto 96-well plates
(100 l) at 4°C overnight or for 3 h at 37°C. Plates were then blocked for 1 h
in 1% BSA at RT and washed once before cell addition. Luciferase plasmid
pGL-3 (4 g) was present with all R-Ras or control pCMV plasmids (2 g
plasmid for antibody treatments or 5 g for all other experiments) during
electroporation. Approximately 17 h after electroporation, 32D cells were
harvested with CDS as in Immunoblotting above, washed three times in RPMI
(no phenol red)/1% BSA to remove serum and resuspended in 3 ml of the
same media for adhesion to vitronectin. For adhesion to fibrinogen, cells were
resuspended in adhesion buffer (20 mM HEPES, pH 7.4, 137 mM NaCl, 2.5
mM KCl, 5.5 mM glucose, 2 mM each CaCl2 and MgCl2 and 0.1% BSA). Cells
were diluted to a density of 5  105 cells/ml. Antibodies or inhibitors were
then added to cells as indicated in the figure legends. Cells (5  104/well)
were loaded into plates for 40 min at 37°C in two groups, one for adhesion
and one for measuring total luciferase activity. Wells containing cells desig-
nated for adhesion were washed three times with RPMI/1% BSA to remove
nonadherent cells and the remaining cells were quantitated using a luciferase
assay (Luc-Lite Plus; Packard Instruments, Meriden, CT). All cells expressing
luciferase were detected with a TopCount NXT luminometer (Packard Instru-
ments). The number of cells adhering to BSA was defined as nonspecific and
was subtracted from the number of cells adhering to vitronectin or fibrinogen.
Adhesion was expressed as the percentage of adherent cells per total cells
loaded into the assay. Luciferase activity was linear beyond the total number
of cells used in the assay. To further validate these assay conditions, we
constructed a nonprenylated, activated R-Ras mutant that did not localize to
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the plasma membrane, because membrane localization is required for full
biological function (Oertli et al., 2000). Compared with membrane-localized,
activated R-Ras, the cytosolic R-Ras mutant did not stimulate adhesion to
fibronectin above control levels (unpublished data).
Migration Assay
A 96-well migration plate (Neuroprobe, Gaithersburg, MD) containing a filter
with 3-m-diameter pores was coated with 1 g/ml vitronectin on the
underside of the filter and incubated at 4°C for 7 h. The coating solutions were
then removed and the bottom chambers including the underside of the filters
were washed once with 30 l of RPMI containing 0.1% BSA. Prewarmed 32D
medium (30 l) was added to the bottom wells to establish a serum gradient
for cells to be added on top of the filter.
After electroporation of 5 g pCMV plasmid plus 4 g pGL-3 luciferase
plasmid, 32D cells were allowed to recover in 10-cm dishes for 7 h at 37°C.
Cells were harvested using 3 ml of prewarmed CDS as in Immunoblotting and
collected by mild centrifugation. Cells were washed in RPMI (no phenol
red)/0.1% BSA three times to remove remnants of serum and counted on a
hemocytometer. Cell number was adjusted to 2  106 cells/ml and 9–10  104
cells in 50 l were loaded on top of each filter in triplicate. For inhibitor
studies, 1  106 cells were treated with 0.37% dimethyl sulfoxide (DMSO) or
25 M LY294002 for 30 min at 37°C and then loaded as above. Cells migrated
for 15–18 h at 37°C. After migration, cells remaining on top of the filter were
removed by aspiration. EDTA (3 mM, in 50 l) was added to the top of the
filter to loosen cells attached to the underside (30 min at 4°C). The top of the
filter was washed once with 50 l of RPMI/0.1% BSA, and cells were trans-
ferred to a new 96-well plate for detection of luciferase activity as described
in Cell Adhesion Assay. An aliquot of total cells was treated with 30 l serum
to mimic migration conditions and to control for any proliferation effects
during the course of the assay. Migration was expressed as the percentage of
migrated cells per total cells loaded into the assay (1  105).
Flow Cytometry
For detection of IIb3 integrin, 32D cells were electroporated with 5 g of
pCGN plasmids, washed three times in cold PBS/1% BSA, resuspended in 2
ml of the same buffer, and incubated with 3 g/ml either hamster IgG control,
anti-3 integrin (clone 2C9.G2; PharMingen, San Diego, CA) or anti-IIb3
antibody 1B5 for 30 min on ice. Cells were washed once and incubated with
10 g/ml FITC-conjugated goat anti-mouse immunoglobulin (Ig) F(ab)2
(Biosource International, Camarillo, CA) for 30 min on ice in the dark. This
secondary antibody cross-reacts with hamster Ig isotypes. Cells were washed
again and resuspended in 500 l, and fluorescence was detected by a FAC-
Scan flow cytometer (Becton-Dickinson, Mountain View, CA).
For fibrinogen binding, 32D cells were electroporated with 6 g of the
indicated GFP plasmids. After 18–19 h, cells were washed three times with
RPMI/0.1% bovine serum albumin, left untreated, or pretreated with 500 M
MnCl2, which was used to activate integrins. All cells were incubated with
Alexa 546–conjugated fibrinogen (Molecular Probes) at 90–100 g/ml for 30
min at RT in the dark. Cells were washed once, resuspended in 500 l of the
above media, and analyzed with a FACScan as above.
Rac Activation Assay
Mouse 32D cells (1–5  107) were electroporated with 5 g of empty pCGN
vector, pCGN N87L R-Ras or pCGN Q87L R-Ras and allowed to recover for
19 h. Cells were washed twice with RPMI/0.1% BSA, washed twice more with
RPMI alone, and plated onto 60-mm dishes precoated with 10 g/ml vitro-
nectin for 1 h at 37°C. For PI3K inhibition, 25 M LY294002 or 0.1% DMSO
was added to cells for 15 min at 37°C before plating. Unbound cells were
removed by aspiration and the remaining adherent cells were lysed in lysis
buffer (25 mM HEPES, pH 7.4, 150 mM NaCl, 1% NP-40, 0.25% deoxycholate,
10% glycerol, 10 mM MgCl2, 50 M Na3VO4, and protease inhibitor cocktail
from CalBiochem) for 25 min on ice. The lysate was clarified and total protein
quantitated using the BioRad reagent. Rac activation was determined as
previously described (Wennerberg et al., 2002) by the addition of GST-Pak1
PBD (p21 binding domain; gift of Dr. Keith Burridge) to 225–375 g of total
protein for 30 min at 4°C. The beads were washed with 10 volumes of lysis
buffer three times, resuspended in 40 l Laemmli sample buffer, and subjected
to SDS-PAGE for immunoblotting. Blots were probed for Rac with the 23A8
monoclonal anti-Rac antibody (1 g/ml; Upstate) in 5% milk/TBST overnight
at 4°C. To detect HA-tagged R-Ras in the whole cell lysate, the blot was
stripped and reprobed with 0.25 g/ml the 12CA5 anti-HA antibody.
Statistics
Data were analyzed with the Student’s one-tailed t test using independent
comparisons. Error bars represent SEM.
RESULTS
Rationale of Mutant Design
R-Ras promotes distinct biological effects that require inte-
grins. To identify sequences within R-Ras that specifically
affect its ability to stimulate integrin-dependent cellular re-
sponses, we analyzed the primary sequences of Ras family
members for sizable regions of nonhomology to identify
candidate domains unique to R-Ras. We targeted the first 26
amino acids of R-Ras since this region represents the largest
contiguous R-Ras sequence having no homology to other
Ras family members and contains the sequence “PGDP,” a
potential SH3 domain-binding motif (Figure 1A). Our strat-
egy was to delete the N-terminal 26 amino acids of consti-
tutively active (Q87L or G38V) R-Ras (Figure 1B). The re-
sulting mutants were N-terminally tagged with myc or
hemagglutinin (HA) epitopes to avoid disruption of the
C-terminal CAAX box and named N87L R-Ras or N38V
R-Ras.
Expression Level of N87L R-Ras
Because mutations in key residues can alter protein expres-
sion, we evaluated N87L R-Ras expression in two different
cell lines. Both myc-tagged N87L and Q87L R-Ras were
Figure 1. R-Ras contains a unique N-terminus that does not alter
protein expression. (A) Shown is a primary amino acid sequence
alignment of Ras family members most closely related to R-Ras. The
initiator methionine of R-Ras is labeled as 1. Conserved regions are
bolded, including the invariant glutamine at position 87. Amino
acids that define a putative SH3-binding domain in the N-terminus
of R-Ras are underlined. (B) A schematic representation of the
full-length versus the truncation mutant of R-Ras lacking its first 26
amino acids is depicted. (C) Whole-cell lysates were prepared from
mouse 32D cells transiently transfected (see Materials and Methods)
with empty pCMV vector (lane 1), N87L R-Ras (lane 2), or Q87L
R-Ras (lane 3). Myc-tagged R-Ras proteins were detected with the
polyclonal anti-R-Ras antibody, C19. Bottom numbers indicate ra-
tios of R-Ras expression normalized to protein phosphatase 2A
levels, which served as a loading control. Myc-tagged R-Ras pro-
teins were also detected in 32D and human K562 cell lysates with
the 9E10 anti-myc monoclonal antibody (unpublished data).
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transiently transfected (see Materials and Methods) into 32D
mouse myeloid cells and detected with an anti-R-Ras poly-
clonal antibody in whole cell lysates (Figure 1C). N-termi-
nally truncated N87L R-Ras exhibited an increased electro-
phoretic mobility compared with full-length Q87L R-Ras.
Both N87L R-Ras and Q87L R-Ras levels were equivalent
when normalized to levels of the abundant cytosolic protein
phosphatase, PP2A. Similar results were obtained with ex-
pression of N87L R-Ras and Q87L R-Ras in K562 cells, a
human erythroleukemic cell line (unpublished data).
Effect of N87L R-Ras on Cell Adhesion
We and others (Zhang et al., 1996) have observed that over-
expressed, activated R-Ras induces robust adhesion of K562
and 32D cell lines to extracellular matrix proteins (ECM). We
therefore asked whether deletion of the N-terminus of R-Ras
affected adhesion of 32D cells using a luciferase reporter
assay, validated as described in Materials and Methods. De-
letion of the N-terminus of R-Ras had little effect on 32D cell
adhesion to vitronectin (Figure 2A), indicating that the N-
terminus of R-Ras is not required for R-Ras-stimulated cell
adhesion. As before, N87L R-Ras protein expression was
equivalent to that of full-length Q87L R-Ras (Figure 2A,
inset). Moreover, adhesion of Q87L R-Ras-transfected cells
to vitronectin was 3 integrin-dependent because an anti-3
but not an anti-1 integrin antibody dramatically inhibited
R-Ras–mediated adhesion (Figure 2B).
Regulation of IIb3 Integrin on 32D Cells by R-Ras
Although R-Ras-induced cell adhesion to vitronectin was
sensitive to an anti-3 antibody (Figure 2B) and the v3
integrin is known to be present on the surface of 32D cells,
we addressed the possibility that the lineage-restricted inte-
grin, IIb3 (Parise, 1999), might also be present. Flow cy-
tometry with 1B5, an IIb3 heterodimer-specific antibody
(Smyth et al., 2000), indicated that IIb3 was expressed on
the surface of nearly 100% of 32D cells. Integrin levels re-
mained unchanged upon expression of activated R-Ras (Fig-
ure 3A). The IIb3 integrin was functional, since Q87L
R-Ras promoted 32D cell adhesion to immobilized fibrino-
gen in a 1B5-sensitive manner (unpublished data).
Because the mechanism by which R-Ras regulates 3 in-
tegrin avidity is unknown, we asked whether R-Ras in-
creased integrin affinity by measuring soluble fibrinogen
binding to 32D cells. Cells expressing activated GFP-G38V
R-Ras or GFP-N38V R-Ras did not bind increased levels of
soluble fibrinogen relative to control cells (Figure 3B, p 
0.4), suggesting that 3 integrins on 32D cells do not un-
dergo “inside-out” affinity modulation in response to acti-
vated R-Ras.
Mechanisms of N87L R-Ras–mediated Cell Adhesion
Because R-Ras does not appear to enhance integrin affinity
for ligand, we further investigated the mechanism of R-Ras–
stimulated cell adhesion by treating R-Ras–overexpressing
32D cells with various pharmacological inhibitors of pro-
teins known to affect integrin-mediated adhesion. N87L
R-Ras- and Q87L R-Ras–mediated adhesion to fibronectin or
vitronectin was not affected by phosphatidylinositol 3-ki-
nase (PI3K) inhibitors such as wortmannin (0.1–10 M) or
LY294002 (1–20 M; unpublished data), consistent with pre-
vious data showing that PI3K is not an essential down-
stream R-Ras effector for cell adhesion (Osada et al., 1999;
Kinashi et al., 2000). Inhibitors of protein kinase C (bisin-
dolylmaleiamide), Src-family kinases (PP2), tyrosine kinases
(genistein), VEGF receptors, calpain (calpeptin), and p70 S6
kinase (rapamycin) also did not affect G38V R-Ras–depen-
dent cell adhesion to fibronectin (unpublished data). How-
ever, filamentous actin (F-actin) poisons such as latrunculin
B and cytochalasin D, which prevent actin filament elonga-
tion, as well as the serine, threonine phosphatase inhibitor
calyculin A completely blocked N87L R-Ras– and Q87L
R-Ras–dependent cell adhesion to vitronectin (Figure 4).
Finally, as a negative control, we observed that dominant-
negative R-Ras (S43N) failed to induce adhesion to vitronec-
tin (Figure 4). These results indicate that R-Ras signaling
requires an intact actin cytoskeleton and predict that R-Ras
Figure 2. The N-terminus of R-Ras is not critical for integrin-
dependent cell adhesion to vitronectin. (A) Mouse 32D cells were
transiently cotransfected with empty pCMV vector, pCMV N87L
R-Ras, or pCMV Q87L R-Ras plus pGL-3, a luciferase reporter
plasmid. Cells (50,000) were loaded into a 96-well plate coated with
the indicated concentrations of vitronectin. Cells were incubated for
40 min, washed, and assayed for luciferase activity (see Materials and
Methods). Cells not used for adhesion were lysed to determine
expression levels of truncated and full-length R-Ras (Figure 2A,
inset). (B) 32D cells were cotransfected with pCMV Q87L R-Ras and
pGL-3 and pretreated with the indicated integrin blocking antibod-
ies at the indicated concentrations for 15 min at RT. Cells were
loaded onto wells coated with 0.5 g/ml vitronectin in the presence
of antibodies and assayed for adhesion as in A. Means of triplicate
samples  SEM from a representative experiment are shown for
both A (n 5 experiments) and B (two experiments).
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influences actin filament formation and/or protein phospha-
tase activity in a manner that does not require the N-termi-
nus of R-Ras.
Colocalization of N87L R-Ras with Filamentous Actin
at the Plasma Membrane
The requirement of the actin cytoskeleton for R-Ras–medi-
ated adhesion (Figure 4) and the known localization of R-
Ras to the plasma membrane via C-terminal lipid modifica-
tions (Ohba et al., 2000), suggest that R-Ras may colocalize
with F-actin at dynamic plasma membrane regions. Before
comparing R-Ras localization relative to F-actin, we first
assessed the impact of the 26 amino acid deletion on R-Ras
sorting to the plasma membrane. Both Q87L R-Ras and
N87L R-Ras targeted to the plasma membrane compared
with control cells (Figure 5, e and i). This was confirmed in
live cells with GFP-tagged R-Ras (unpublished data), similar
to that reported by Ohba et al. (2000). When coexpressed in
the same cell, the two proteins colocalized exactly at the
plasma membrane in most cells examined, especially in
dorsal focal planes (unpublished data), suggesting that trun-
cation of the R-Ras N-terminus does not preclude lipid
insertion into the plasma membrane and affect GTPase lo-
calization.
We next determined whether R-Ras was present in re-
gions of the plasma membrane that contained F-actin and
found that in most transfected cells, both Q87L R-Ras and
N87L R-Ras colocalized with F-actin in ribbon-like mem-
brane ruffles (Figure 5, g–h, and k–l). Ruffles were usually
concentrated at the cell periphery in dorsal focal planes, but
could also be seen in more central locations above the cell
body. Q87L R-Ras also colocalized with F-actin in filopodia
in a fraction of polarized cells (Figure 5h). In contrast, nei-
ther protein was abundant in actin-rich lamellipodia (Figure
5, h and l). Control cells displayed well-polarized F-actin
upon adhesion to vitronectin, but remained generally round
in shape (Figure 5, a–d). Both R-Ras mutants, therefore,
show very similar localization patterns to actin-rich mem-
brane structures in 32D cells.
Generation of a Protrusive Morphology by N87L R-Ras
Although colocalization of R-Ras with actin was indepen-
dent of the N-terminus, we observed during the course of
these studies that N87L R-Ras generated cell morphologies
quite different from Q87L R-Ras–transfected and vector con-
trol cells. These morphological differences became more pro-
nounced with higher expression levels of N87L R-Ras. To
investigate these morphological differences in more detail,
we determined the number of transfected cells having de-
fined morphologies and the molecular mechanisms under-
lying these differences.
Q87L R-Ras induced a flattened, asymmetric cell morphol-
ogy (Figure 6A, d–f), with some cells having polarized actin
Figure 3. Integrin IIb3 is present on 32D cells but R-Ras does
not increase 3 integrin affinity for ligand. (A) Mouse 32D cells were
cotransfected with empty pCGN control vector or pCGN Q87L
R-Ras plus pGL-3. Cells were analyzed by flow cytometry using
control hamster IgG (gray histograms), the anti-3 antibody, 2C9.G2
(black histograms) or the anti-IIb3 antibody, 1B5 (black histo-
grams). (B) As a positive control, mouse 32D cells were treated with
Mn2 to activate integrins or transfected with the negative control
GFP-tagged dynamin 2 (Con), GFP-N38V R-Ras (N38V) or GFP-
G38V R-Ras (G38V). Alexa 546–conjugated fibrinogen binding to
GFP-transfected cells was assessed by flow cytometry. Specific bind-
ing was determined by subtracting nonspecific fibrinogen binding
occurring in the presence of an inhibitory 3 integrin antibody,
2C9.G2, from total fibrinogen binding. Results were expressed as
the mean percentage  SEM of transfected cells specifically binding
fibrinogen from four experiments.
Figure 4. Inhibition of actin polymerization and phosphatase ac-
tivity block R-Ras–dependent cell adhesion. Mouse 32D cells were
cotransfected with empty pCGN control vector, pCGN N87L R-
Ras, pCGN Q87L R-Ras, or pCGN S43N R-Ras plus pGL-3 and
assayed for cell adhesion as described in Figure 2A. Cells were
pretreated with the indicated concentrations of latrunculin B (LB),
cytochalasin D (CD), calyculin A (CA), or 0.1% DMSO control for 30
min at 37°C before adhesion to vitronectin. Data represent triplicate
means of a representative experiment from four independent trials.
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filaments (Figure 6A, e). In contrast, N87L R-Ras stimu-
lated the formation of long, thin extensions (Figure 6A, g–l).
These extensions radiated from random positions along a
round cell body proximal to the cell-matrix interface and
resembled actin microspikes (Kozma et al., 1995). Nearly
60% of all N87L R-Ras–transfected cells displayed two or
more extensions (Figure 6B) and 33% displayed four or more
extensions, which were often highly branched (Figure 6C).
In Q87L R-Ras–expressing cells, extensions were observed
at a significantly lower frequency and were less branched
(37%, Figure 6B; 14%, Figure 6C).
Because the small Rho GTPase, Rac, can induce an elon-
gated morphology similar to that described above (Sahai
and Marshall, 2003) and because Rac can act downstream of
R-Ras during cell spreading (Berrier et al., 2000), we asked
whether the N87L R-Ras–induced protrusive phenotype re-
quires Rac. Dominant-negative Rac (DN-Rac) blocked the for-
mation of these protrusive structures in N87L R-Ras–
expressing cells by 81%, suggesting that N87L R-Ras requires
Rac-GTP to produce an elongated phenotype (Figure 6C).
Effects of N87L R-Ras on Rac Activation
The findings that R-Ras colocalizes with actin structures
(Figure 5) and N87L R-Ras induces a Rac-dependent pro-
trusive phenotype (Figure 6) suggest that R-Ras acts locally
to regulate Rac activity. However, it is not known whether
R-Ras directly activates Rac to facilitate actin remodeling or
whether Rac contributes to R-Ras function via a parallel but
independent pathway. We therefore performed Rac “pull-
down” assays (Wennerberg et al., 2002) to determine
whether R-Ras increased Rac activity. Full-length Q87L R-
Ras boosted Rac activation in cells plated on vitronectin by
nearly threefold compared with control cells (Figure 7, A
and B). In contrast, N87L R-Ras had no effect on Rac
activation (Figure 7, A–D). These results indicate that the
N-terminus of R-Ras is required for Rac activation and that
the Rac-dependency of the N87L R-Ras–mediated protru-
sive phenotype observed above (Figure 6) may reflect a
requirement for basal as opposed to stimulated Rac-GTP
levels.
Because PI3K generates lipids that stimulate Rac guanine
nucleotide exchange factor (GEF) activity and Rac GTP load-
ing (Nimnual et al., 1998; Han et al., 1998), we next asked
whether PI3K contributed to R-Ras–stimulated Rac activa-
tion (Marte et al., 1997). The PI3K inhibitor, LY294002, inhib-
ited full-length R-Ras–induced Rac-GTP loading by 72%
(p  0.03; Figure 7, C and D), but failed to block the low level
of Rac activation present in cells expressing either empty
vector or N87L R-Ras, consistent with the inability of
N87L R-Ras to activate Rac. These results demonstrate that
full-length R-Ras requires PI3K for complete Rac activation.
Effects of N87L R-Ras and Rho GTPases on Cell
Spreading
To independently confirm that the N-terminus of R-Ras is
important for Rac activation, we compared the morpholog-
ical phenotypes of 32D cells expressing activated Rac (Q61L)
or the closely related Rho GTPase, Cdc42 (Q61L), to full-
length Q87L R-Ras or truncated N87L R-Ras. In these
experiments, less R-Ras plasmid was transfected to mini-
mize the protrusive phenotype described in Figures 5 and 6
and favor a rounder, more traditional Rac-like phenotype.
The 32 cells expressing activated Rac displayed a morphol-
ogy resembling that of fibroblasts expressing activated Rac
(Hall, 1998): large, round, highly spread cells with abundant
membrane ruffles (Figure 8A). Similarly, cells expressing
full-length Q87L R-Ras showed a spread morphology nearly
identical to cells expressing activated Rac (Figure 8A). We
defined this Rac-like morphology as round, spread cells
having a cell area greater than 400 m2 and found that 50%
of Q87L R-Ras–expressing cells displayed this phenotype
(Figure 8B). These cells had a mean cell area of 1077 m2,
which is nearly threefold greater than the mean cell area of
389 m2 for control cells (Figure 8C).
In contrast, cells expressing truncated N87L R-Ras dis-
played a spreading defect characterized by fewer large cells
and decreased cell area compared with cells expressing full-
length R-Ras or Rac (Figure 8A). Only 27% of N87L R-Ras–
expressing cells showed a Rac-like morphology as defined
above (Figure 8B) and their mean cell area was 609 m2,
nearly twofold less than Q87L-expressing cells (Figure 8C).
Thus, the N-terminus of R-Ras is important for the ability of
R-Ras to promote a highly spread morphology, similar to
that of activated Rac. Although Cdc42 is proposed to be
upstream of Rac in fibroblasts (Nobes and Hall, 1995), 32D
cells expressing activated Cdc42 did not produce a pheno-
type similar to that of Rac, nor did these cells resemble
Figure 5. Activated R-Ras colocalizes with ac-
tin in filopodia and membrane ruffles. Mouse
32D cells were transfected with pCGN vector
alone (one cell shown in a–d), pCGN Q87L
R-Ras (one cell shown in e–h), or pCGN N87L
R-Ras (one cell shown in i–l). An anti-HA anti-
body, 12CA5, was used to detect R-Ras (e and i)
and Alexa 568-phalloidin was used to detect
F-actin (b, f, and j). “Merge” signifies an overlay
of two single focal plane images 0.15-m-
thick collected by z-series scanning, whereas
“smash” refers to an overlay of all slices in the
z-series and thus reveals additional data. Im-
ages of single focal planes depict dorsal sec-
tions of the cells. Arrowheads in panel g and k
point to membrane ruffles at the cell periphery.
The arrow in panel h indicates an actin “rib” or
filopod associated with a lamellipod.
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fibroblasts microinjected with activated Cdc42 (Hall, 1998;
unpublished data).
We then asked whether these phenotypes required Rac by
cotransfecting dominant-negative Rac (DN-Rac) with full-
length or truncated R-Ras. DN-Rac blocked 71% of Q87L
R-Ras–induced Rac-like morphology but only 57% of N87L
R-Ras–induced morphology (Figure 8B). Because DN-Rac
should block both basal and R-Ras–mediated Rac activation,
the partial inhibition of N87L R-Ras–induced morphology
by DN-Rac presumably represents a Rac-independent mode
of cell spreading. DN-Rac reduced the mean cell area of
Q87L R-Ras–expressing cells below control levels to 326
m2 (Figure 8C), demonstrating that Rac is required for
R-Ras–induced cell spreading.
Effects of N87L R-Ras on PI3K Activation
To explore why N87L R-Ras failed to activate Rac, we
tested the ability of N87L R-Ras to activate PI3K via phos-
phorylation of a common PI3K effector, Akt. Like full-length
R-Ras, N87L R-Ras enhanced Akt phosphorylation com-
pared with a vector alone control (Figure 9), revealing that
the N-terminus of R-Ras is not required for PI3K activation
in 3T3 cells. Akt phosphorylation was dependent on PI3K
since LY294002 inhibited 90% of R-Ras–induced Akt phos-
phorylation. These data demonstrate that the inability of
N87L R-Ras to activate Rac does not stem from defective
initiation of PI3K signaling.
Effects of N87L R-Ras on Cell Migration
Previous data by Keely et al. (1999) showed that activated
R-Ras stimulates haptotaxis, or cell movement in the direc-
tion of an ECM gradient. Because we observed that mouse
32D cells do not undergo efficient haptotaxis, we tested the
ability of N87L R-Ras or Q87L R-Ras to stimulate 32D cell
migration in the presence of a serum gradient through 3 m
pores (see Materials and Methods). N87L R-Ras–expressing
32D cells migrated almost three times more than control
cells (Figure 10A; 11  1.9% for N87L R-Ras vs. 4.2  1.2%
for control cells) and 26% more than Q87L R-Ras–expressing
cells (Figure 10A; 11  1.9% for N87L R-Ras vs. 8.1  0.97%
for Q87L R-Ras, p  0.04), implicating the N-terminus of
R-Ras as a negative regulator of cell migration.
To test the mechanism of R-Ras–stimulated cell migration,
we blocked the function of proteins putatively involved in
Figure 6. The absence of the N-terminus of R-Ras produces a Rac-dependent dendritic morphology. Mouse 32D cells were transfected as
in Figure 2A (without pGL-3) and adhered to coverslips. (A) Myc-tagged R-Ras was visualized with the 9E10 monoclonal antibody (mAb)
and filamentous actin was stained with Alexa 568-phalloidin. Shown are a representative nonspreading control cell (a–c) and a representative
cell expressing Q87L R-Ras (d–f). The bottom six panels depict two cells expressing N87L R-Ras (first cell, g–i; second cell, j–l). The merged
image is an overlay of two single focal planes near the ventral surface of the cells. (B) The filopodia-like morphology of the 32D cells having
two or more protrusions (A, cells g–l) was scored microscopically by an observer who was unaware of sample identity. Data represent means
from three independent experiments (*p 	 0.007). (C) The percentage of cells containing four or more protrusions was scored in cells
transfected with empty vector (n 	 347), N87L R-Ras (n 	 959) or Q87L R-Ras (n 	 1002), N87L R-Ras plus DN-Rac (n 	 442) or DN-Rac
alone (n 	 255). Data represent means from three independent experiments (*p  0.03 for N87L vs. Q87L and p  0.02 for N87L vs.
N87LDN Rac).
S. P. Holly et al.
Molecular Biology of the Cell2464
this process such as 3 integrins, PI3K and Rac. Migration of
32D cells was partially dependent on 3 integrins, because
an anti-3 antibody reduced migration by 42% for vector
control cells, 51% for N87L R-Ras cells and 54% for Q87L
R-Ras cells (Figure 10B). Although Q87L R-Ras–mediated
migration was partially blocked by the selective PI3K inhib-
itor, LY294002 (44%, p 	 0.02), N87L R-Ras–mediated mi-
gration was not significantly affected (Figure 10C). Unex-
pectedly, DN-Rac did not significantly inhibit Q87L R-Ras–
or N87L R-Ras–mediated migration (mean inhibition of
13%; Figure 10D). Taken together, these data indicate the
importance of integrin-mediated adhesion and/or signaling
during cell migration but also point toward a PI3K- and
Rac-independent pathway stimulated by N87L R-Ras, dis-
tinct from pathways initiated by Q87L R-Ras.
To discriminate between chemokinesis, which is random
cell movement, and chemotaxis, which is directed move-
ment toward a chemoattractant gradient (Parent and Dev-
reotes, 1999; Rickert et al., 2000), we compared the move-
ment of cells in the presence and absence of a serum
gradient (Figure 10E). As cells were exposed to increasing
serum concentrations above the transwell, which destroys
the gradient, the percentage of Q87L R-Ras–expressing 32D
cells moving to the bottom chamber increased compared
with vector-transfected cells. This result indicated that R-Ras
amplifies a chemokinetic rather than chemotactic form of
cell movement.
DISCUSSION
The first study to focus on the role of the N-terminus of
R-Ras was conducted by Lowe and Goeddel (Lowe et al.,
1987). They found that a 26 amino acid truncation mutant
behaved like full-length R-Ras, weakly causing cell transfor-
mation and growth in soft agar compared with robust effects
induced by H-Ras. The function of the divergent R-Ras
N-terminus was therefore unknown and attention was
shifted to more C-terminal sequences. Since that time, R-Ras
has been shown to dramatically affect integrin-dependent
cellular processes such as adhesion, spreading, migration,
and invasion (Zhang et al., 1996; Keely et al., 1999; Berrier et
al., 2000). Two recent studies have shown that the R-Ras
N-terminus is involved in neither protein targeting to focal
adhesions (Furuhjelm and Peranen, 2003) nor in the rescue
of chimeric integrin activation from H-Ras–induced integrin
suppression (Hansen et al., 2002). In the present study, we
truncated the first 26 amino acids of R-Ras in the context of
an activating point mutation (N87L R-Ras) to address the
role of the unique N-terminus relative to distinct integrin-
dependent events. Although the presence or absence of the
R-Ras N-terminus does not affect the membrane localization
of R-Ras or its ability to induce integrin-dependent cell
adhesion, the N-terminus negatively regulates R-Ras–in-
duced cell movement and positively regulates Rac activa-
tion.
Regulation of Cell Adhesion by R-Ras
Multiple studies have demonstrated a clear role for R-Ras in
integrin-dependent cell adhesion (Zhang et al., 1996; Osada
et al., 1999; Kinashi et al., 2000). Even though we found that
R-Ras could dramatically increase cell adhesion to immobi-
lized substrates, deletion of the N-terminus of R-Ras had
little effect on this event. Although the pathway by which
R-Ras induces cell adhesion is still incomplete, we provide
evidence that F-actin and protein phosphatases such as
PP2A are required. Because actin filaments and phospha-
tases are also necessary for basal 32D cell adhesion, overex-
pression of GTP-bound R-Ras likely amplifies an endoge-
nous signaling pathway that normally regulates actin
organization and/or phosphatase activity during integrin-
dependent adhesion events. Proteins that increase mem-
brane fluidity or contact integrins directly such as talin are
also good candidates for R-Ras effectors (Calderwood, 2004).
Two possible modes of integrin avidity regulation,
namely affinity modulation of individual integrins and or-
ganization of multiple low-affinity interactions, each result
in enhanced cell adhesion (Keely et al., 1998). R-Ras has been
proposed to increase the affinity of the platelet integrin
IIb3 expressed in suspended Chinese hamster ovary cells
(Zhang et al., 1996) by a mechanism called “inside-out sig-
Figure 7. Full-length but not truncated R-
Ras stimulates Rac activation in a PI3K-de-
pendent manner in 32D cells. Mouse 32D cells
were transfected as in Figure 6, washed four
times, and adhered to 60-mm dishes coated
with 10 g/ml vitronectin for 1 h. Adherent
cells were lysed and recombinant GST-Pak1
PBD was used to precipitate GTP-bound Rac.
R-Ras expression levels were determined in
whole-cell lysates by reprobing the same blot
using an anti-HA mAb (bottom panel). (A)
Lane 1, empty vector control; lane 2, N87L
R-Ras; and lane 3, Q87L R-Ras. (B) Relative
Rac activation was calculated by dividing
Rac-GTP by total Rac present in whole cell
lysates (*p  0.002 for Q87L vs. N87L).
Shown is the mean  SEM of three indepen-
dent pull-down experiments (control n 	 2).
(C) Cells were transfected as in A and treated
with 0.12% DMSO or 25 M LY294002 for 30
min at 37°C before plating for 1 h as above.
An example of four independent experiments
is shown. Lane 1, vector control  DMSO;
lane 2, N87L R-Ras  DMSO; lane 3, N87L
R-Ras  LY; lane 4, Q87L R-Ras  DMSO;
and lane 5, Q87L R-Ras  LY. (D) Inhibition of Rac activation by LY294002 was calculated as in B. Data represent the mean  SEM of four
independent experiments (*p  0.03 for Q87L vs. Q87L  LY).
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naling” (reviewed in Parise, 1999). Our data as well as
results from other investigators show that neither full-length
(Sethi et al., 1999) nor truncated R-Ras (this study) signifi-
cantly increase binding of soluble agonists to suspension
cells. This implies that R-Ras is unlikely to induce cell ad-
hesion via affinity modulation of integrins in 32D cells.
However, the fact that R-Ras did increase IIb3 integrin
binding to immobilized fibrinogen demonstrates its func-
tionality in a myeloid cell line. Thus, we favor a model in
which R-Ras signaling in 32D cells directly increases cell
adhesion by a mechanism largely independent of integrin
affinity modulation.
Colocalization of R-Ras with Actin
We find that both N87L R-Ras and Q87L R-Ras colocalize
with F-actin in dynamic plasma membrane structures such
as peripheral membrane ruffles and filopodia. Ruffles are
thought to be important for cellular events involving uptake
of fluids or microorganisms (Ridley et al., 1992). Consistent
with this localization, activated R-Ras has been shown to
enhance phagocytosis of opsonized red blood cells in a
Figure 8. Full-length R-Ras produces a Rac-like, spread morphology but truncated R-Ras fails to induce maximal spreading. (A) Cells were
transfected as indicated and treated as in Figure 7, except that cells were plated on 0.5 g/ml vitronectin (CA, constitutively active). An
anti-HA antibody, 12CA5, was used to detect R-Ras and a polyclonal c-myc antibody was used to detect myc-tagged Rac. (B) Rac-like
phenotypes of cells shown in A were scored by microscopically counting the percentage of randomly chosen transfected cells having the Rac
phenotype defined as a round, cell area greater than 400 m2. Phase micrographs were used for control cells not expressing epitope-tagged
proteins. Each bar represents 190 cells for CA-Rac, 271 cells for pCGN, 307 cells for N87L, 275 cells for N87LDN-Rac, 384 cells for Q87L,
374 cells for Q87LDN-Rac, and 364 cells for DN-Rac alone. (C) The total cell area of empty vector control cells (n 	 31), N87L
R-Ras–expressing cells (n 	 25, *p  0.00003 vs. Q87L), Q87L R-Ras–expressing cells (n 	 15), and Q87L R-Ras  DN-Rac coexpressing cells
(n 	 8) was examined using ImagePro software.
Figure 9. N87L R-Ras and Q87L R-Ras activate PI3K in 3T3 cells.
NIH 3T3 cells were transfected with empty pCMV vector (lanes 1
and 2), pCGN N87L R-Ras (lanes 3 and 4) or pCGN Q87L (lanes 5
and 6). Cells were treated with 0.37% DMSO (odd lanes) or 25 M
LY294002 (even lanes) for 30 min and lysed. Whole cell lysates were
subjected to SDS-PAGE and phosphorylation of Akt on serine 473
was detected with a polyclonal antibody. Phosphorylated Akt was
used as a reporter of PI3K activation. The phospho-Akt blot was
stripped and reprobed for HA-tagged R-Ras using the 12CA5 mAb.
Total Akt was detected with a distinct polyclonal antibody to assess
protein loading.
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macrophage-like cell line (Caron et al., 2000). Filopodia are
putative environmental sensors that extend beyond the pe-
riphery of the cell and interpret extracellular stimuli, guid-
ing directed cell movement (Small et al., 2002; Svitkina et al.,
2003). Therefore, R-Ras may be acting locally on the actin
cytoskeleton to influence cell adhesion and other cellular
processes that require navigation such as leukocyte chemo-
taxis, neuronal migration, or embryonic tissue patterning.
In contrast to colocalization with actin in membrane ruf-
fles and filopodia, both truncated and full-length R-Ras were
largely excluded from the branched actin network present in
lamellipodia, indicating that activated R-Ras primarily asso-
ciates with a subset of actin structures within the cell. By
localizing to the plasma membrane and certain actin-rich
structures, however, N87L R-Ras behaved like the parental
Q87L R-Ras protein and other Ras family members, reinforc-
ing the idea that sequences in the hypervariable region
(HVR) of Ras GTPases are responsible for intracellular tar-
geting (Choy et al., 1999; Bondeva et al., 2002).
Rac Activation by R-Ras
The small GTPase Rac has been implicated downstream of
R-Ras signaling during cell spreading, a step thought to
precede cell migration in fibroblasts (Berrier et al., 2000;
Borisy and Svitkina, 2000). We show here that full-length
Q87L R-Ras but not N87L R-Ras greatly enhances Rac
activation in adherent 32D cells. Furthermore, when acti-
vated Rac is coexpressed with N87L R-Ras in the same cell,
a round, Rac-like morphology replaces the protrusive
N87L R-Ras morphology, which is consistent with the
inability of N87L R-Ras to activate Rac (unpublished data).
We investigated the mechanism of full-length R-Ras–de-
pendent Rac activation by testing the lipid kinase, PI3K.
PI3K is perfectly positioned to link R-Ras and Rac since it is
a well-recognized in vivo effector of R-Ras (Marte et al., 1997)
as well as an upstream activator of many Rac guanine nu-
cleotide exchange factors (Han et al., 1998; Nimnual et al.,
1998; Welch et al., 2003). The PI3K inhibitor, LY294002,
blocked R-Ras–dependent Rac activation almost completely
in 32D cells, indicating that full-length R-Ras does indeed
stimulate Rac activation through PI3K but may utilize addi-
tional effectors as well. However, in 3T3 cells, both full-
length and truncated R-Ras stimulated comparable levels of
Akt phosphorylation, indicating that both forms of R-Ras
can activate PI3K in vivo. The molecular explanation as to
why N87L R-Ras activates PI3K but does not increase Rac
GTP loading is presently unknown but may be due to the
differences in cell type and/or kinetics of the Akt phosphor-
ylation versus Rac activation assays. Alternatively, the un-
coupling of PI3K activity from Rac activation may imply that
an additional undefined signaling input is necessary for Rac
activation in vivo.
Figure 10. Removal of the R-Ras N-terminus
increases cell migration in response to serum.
(A) Mouse 32D cells were transfected as in
Figure 2A. The underside of a 96-well plate
embedded with 3-m pores was coated with
1 g/ml vitronectin. Serum-containing media
was placed in the bottom chamber and 1 
105 cells were loaded on top of the chamber.
Migration was expressed as the percentage of
migrated luciferase-expressing cells (**p 	
0.001 for N87L R-Ras vs. vector control and
*p  0.006 for Q87L R-Ras vs. vector control;
p  0.04 for N87L R-Ras vs. Q87L R-Ras).
Data represent triplicate means from five ex-
periments  SEM (B) Cells were transfected
as above but were pretreated with an anti-in-
tegrin 3 antibody (clone 2C9.G2) or control
hamster IgG for 30 min at 37°C. Percent inhi-
bition of migration was calculated according
to the formula: (migrationIgG 
 migration3)/
migrationIgG 100 and represents means
from three independent experiments  SEM.
(C) Cells were transfected as above and
treated with 0.37% DMSO or 25 M LY294002
for 30 min at 37°C. Cells were allowed to
migrate in the presence of these reagents. Per-
cent inhibition was calculated according to the
formula: (migrationDMSO 
 migrationLY) /
migrationDMSO 100. Data represent means
from three independent experiments  SEM
(*p 	 0.02 for DMSO vs. LY294002). (D) Cells
were transfected with pCGN R-Ras plasmid
alone or pCGN R-Ras plus pCMV DN-Rac as
indicated such that the amount of DNA totaled
12 g for each condition. Cell migration was
performed as above, except that a migration
index was calculated by normalizing migration
values to R-Ras levels determined by densitom-
etry of anti-HA immunoblots. Control cells are not shown because the data cannot be normalized to R-Ras expression levels. Data represent
means  SEM from two separate experiments. (E) Checkerboard analysis was performed to determine if migration to serum was chemotactic.
Mouse 32D cells were transfected as in Figure 6 and resuspended in 0, 0.5, 10, or 20% serum-containing media (abscissa) and allowed to migrate
toward 0.5% serum-containing media in the bottom chamber. Shown is a representative experiment from two independent trials.
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Consistent with Rac activation, full-length R-Ras pro-
motes a spread morphology nearly identical to that of acti-
vated Rac in 32D cells adhering to vitronectin in the absence
of other stimuli. This phenotype requires Rac, as DN-Rac
almost completely inhibited Q87L R-Ras–stimulated spread-
ing. However, cells expressing truncated R-Ras display a
spreading defect characterized by a decreased cell area,
suggesting an inability of these cells to protrude membranes.
Because truncated R-Ras stimulates integrin-dependent cell
adhesion in 32D cells, the spreading defect likely does not
result from suboptimal integrin binding to immobilized li-
gand. Alternatively, this spreading defect may result from
inefficient “outside-in” signaling generated by ligand occu-
pied integrins. Kwong et al. (2003) have shown that R-Ras
enhances “outside-in” signals downstream of integrin liga-
tion, resulting in increased focal adhesion formation in
breast epithelial cells. Because integrins are known to regu-
late Rac activation upon adhesion to extracellular matrix
ligands (Price et al., 1998), it is tempting to speculate that
R-Ras, via its N-terminal domain, may activate Rac as part of
a postadhesion integrin signaling pathway. This pathway
may be cell type–specific, however, as activated R-Ras has
recently been reported to reduce rather than increase levels
of activated Rac in epithelial cells (Wozniak et al., 2005).
Regulation of Cell Migration by R-Ras
R-Ras is known to induce haptotaxis in breast epithelia and
skeletal myoblasts (Keely et al., 1999; Holly et al., 2000;
Suzuki et al., 2000). We extend this observation further by
showing that Q87L R-Ras potentiates chemokinesis or ran-
dom cell movement driven by the presence of serum. Inter-
estingly, N87L R-Ras induces significantly more cell move-
ment than full-length Q87L R-Ras and control cells under
these conditions, suggesting a negative regulatory role for
the N-terminus. Wozniak et al. (2005) also find evidence of a
role for R-Ras in chemokinesis; depletion of endogenous
R-Ras levels via RNAi in breast epithelial cells results in a
dramatic loss of cell motility on collagen. These data suggest
that R-Ras may be fundamentally important for cell move-
ment and further implicate R-Ras in the regulation of cy-
toskeletal dynamics. Moreover, chemokinetic movement
may be an important prerequisite for metastatic spread and
invasion of tumor cells.
To provide further evidence of a negative regulatory role
for the R-Ras N-terminus during chemokinesis, we con-
structed a chimera comprised of the R-Ras N-terminus fused
to the N-terminus of the entire TC21 polypeptide, a close
relative of R-Ras. Contrary to our prediction, this chimera
did not exhibit decreased cell migration levels compared
with TC21 (unpublished data), indicating that the N-termi-
nus of R-Ras is not a modular domain but more likely a
region that acts in a sequence specific manner to regulate
protein activity. However, a replacement of the short N-
terminus of TC21 might have yielded different results.
Cell migration often requires PI3K, which is a common
effector for many Ras GTPases (Sasaki et al., 2000; Ridley,
2001). Pharmacological inhibition of PI3K with LY294002
blocks full-length R-Ras–mediated chemokinesis by 44%,
but blocks truncated R-Ras–mediated chemokinesis by only
25%. This confirms that truncated R-Ras does not rely
heavily on PI3K for cell migration, which is consistent with
its inability to activate Rac.
The elongated, protrusive morphology of N87L R-Ras–
expressing cells partially explains why these cells migrate
more efficiently than Q87L R-Ras–expressing cells. Rac can
generate similar elongated cell morphologies in colon and
squamous carcinoma cells in combination with growth fac-
tors in matrigel (Sahai and Marshall, 2003). Because DN-Rac
blocked the ability of truncated R-Ras to promote an elon-
gated, dendritic phenotype but only blocked migration by
roughly 10%, we conclude that an elongated cell shape
accounts for a fraction of the total migration response under
these conditions. This phenotype may be more relevant for
other types of migratory conditions, however, such as inva-
sion through soft agar or chemotaxis.
The apparent paradox that N87L R-Ras induces more
cell migration than full-length Q87L R-Ras but fails to fully
activate Rac, may be explained by two observations. First,
DN-Rac only slightly reduced R-Ras–dependent migration,
suggesting that Rac activation is not crucial for this process.
Second, rac1
/
 mouse macrophages migrate normally de-
spite defects in cell spreading, similar to cells expressing
N87L R-Ras (Wells et al., 2004). These data emphasize the
importance of Rac-independent signaling pathways leading
to cell migration.
In summary, the N-terminus of R-Ras is necessary for the
efficient dissemination of R-Ras signals that govern cell
shape and migration capacity. Specifically, the unique N-
terminus of R-Ras positively regulates Rac activation and
cell spreading, but slows R-Ras–mediated cell migration. It
is therefore possible that the N-terminus of R-Ras in the
context of the entire GTPase favors the binding of currently
undefined, yet important effectors involved in inte-
grin-dependent cell morphology and migration.
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